Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues:
Premiums	$ 134,751	$ 122,896	$ 99,192
Net investment income	2,233	2,153	1,153
Total revenues	402,067	372,809	357,776
Operating costs:
Cost of products sold	221,167	206,287	217,098
Health care costs	125,538	115,121	86,247
Operating expenses	44,977	41,706	39,832
Goodwill impairment	5,725	0	0
Restructuring charges	0	1,179	507
Loss on assets held for sale	0	0	349
Total operating costs	397,407	364,293	344,033
Operating income	4,660	8,516	13,743
Interest expense	(3,119)	(2,958)	(2,658)
Gain on early extinguishment of debt	0	491	0
Gain on deconsolidation of subsidiary	483	0	0
Other income	112	99	88
Income before income tax provision	2,136	6,148	11,173
Income tax provision	408	1,562	2,805
Net income	1,728	4,586	8,368
Net (income) loss attributable to noncontrolling interests	40	28	(24)
Net income attributable to CVS Health	$ 1,768	$ 4,614	$ 8,344
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 1.40	$ 3.67	$ 6.49
Diluted (in dollars per share)	$ 1.39	$ 3.66	$ 6.47
Weighted average shares outstanding:
Basic (in shares)	1,267	1,259	1,285
Diluted (in shares)	1,271	1,262	1,290
Cost, Product and Service [Extensible Enumeration]	Products	Products	Products
Products
Revenues:
Revenues	$ 249,908	$ 231,521	$ 245,138
Services
Revenues:
Revenues	$ 15,175	$ 16,239	$ 12,293